Policy Brief

Policy Brief Impact of the Inflation Reduction Act on the 340B Program December 4, 2023 The 340b program provides an important revenue source for many HIV clinics and facilities, but that revenue is dependent on drug pricing. The Inflation Reduction Act of 2022 introduced provisions to curb drug pricing. Our modeling suggests that 340b revenues […]

Read More
Policy Brief
Impact of the Inflation Reduction Act on the 340B Program

December 4, 2023

Policy Brief Preferences for pharmacist-initiated PrEP implementation in California: Results of a discrete choice experiment October 20, 2023 A new CHPRC analysis reveals California pharmacists’ preferences for implementing pharmacist-initiated PrEP for HIV prevention under Senate Bill 159. In a discrete choice experiment, pharmacists preferred implementation scenarios in which they play an active role in the […]

Read More
Policy Brief
Preferences for pharmacist-initiated PrEP implementation in California: Results of a discrete choice experiment

October 20, 2023

Policy Brief An Analysis of the Scientific Evaluation of Orange County’s Discontinued Sterile Syringe Distribution Program and Its Implications for Drug Policy in California August 17, 2023 This brief analyzes the impact of Orange County’s sterile syringe distribution program on client and community outcomes, and also assesses how its impact influenced risk of HIV and […]

Read More
Policy Brief
An Analysis of the Scientific Evaluation of Orange County’s Discontinued Sterile Syringe Distribution Program and Its Implications for Drug Policy in California

August 17, 2023

Policy Brief Are California pharmacists ready to provide long-acting injectable pre- exposure prophylaxis (PrEP) for HIV prevention? July 31, 2023 A new CHPRC analysis finds strong potential to increase access to long-acting injectable forms of HIV prevention in California pharmacies. Pharmacists surveyed were highly supportive of pharmacy-based PrEP provision under Senate Bill 159, and more […]

Read More
Policy Brief
Are California pharmacists ready to provide long-acting injectable pre- exposure prophylaxis (PrEP) for HIV prevention?

July 31, 2023

Policy Brief People Living With HIV who Smoke Face Barriers to Accessing Smoking Cessation Services in Southern California HIV Safety Nets May 15, 2023 A new study from the California HIV/AIDS Policy Research Centers finds that less than 30% of safety net providers in the Ryan White HIV/AIDS Program in Southern California offered smoking cessation […]

Read More
Policy Brief
People Living With HIV who Smoke Face Barriers to Accessing Smoking Cessation Services in Southern California HIV Safety Nets

May 15, 2023

Policy Brief Senate Bill 159 Implementation California Pharmacists’ Perspectives on Opportunities and Challenges March 7, 2023 A new study from the California HIV/AIDS Policy Research Centers, in collaboration with the Center on Reproductive Health, Law, and Policy, Birth Control Pharmacist, and the California Society of Health-System Pharmacists, finds that more than 90% of California pharmacists […]

Read More
Policy Brief
Senate Bill 159 Implementation California Pharmacists’ Perspectives on Opportunities and Challenges

March 7, 2023

Policy Brief HIV and the Role of Federal Funds for Sexual and Reproductive Healthcare Serving Women in California February 16, 2023 Sexual and reproductive healthcare and rights (SRHR) are integral to gender equity, HIV prevention, and the provision of high-quality services for people of all genders living with HIV (PLWH).1 Sexual and reproductive healthcare (SRH) […]

Read More
Policy Brief
HIV and the Role of Federal Funds for Sexual and Reproductive Healthcare Serving Women in California

February 16, 2023